Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VESTRI: Safety of Fluticasone/Salmeterol in Pediatric Asthma
NCT01462344Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2011
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 32
01
Overview
A Phase 4 trial of salmeterol in asthma, sponsored by GSK. Started Nov 2011; status: completed.
02
Drugs
salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01462344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01462344.